Edwards Lifesciences Corp (EW) Stock Analysis
Verdict: HOLD
Rapid TMTT expansion and FDA approvals drive top-line growth, but elevated P/E of 51.3x and recall risks cap immediate upside.
Investment score: 63/100
Analysis as of
Is Edwards Lifesciences Corp stock worth reviewing? The TradeMates thesis
The TradeMates model views EW as a high-quality MedTech leader trading at premium valuation multiples that reflect strong growth prospects in tricuspid/mitral structural heart therapies.
7-factor investment score
- Valuation: 45/100 (weight 20%)
- Financial Health: 85/100 (weight 15%)
- Technical Momentum: 65/100 (weight 15%)
- Earnings Quality: 68/100 (weight 15%)
- Insider Sentiment: 30/100 (weight 10%)
- Analyst Consensus: 80/100 (weight 10%)
- Risk-Adjusted Return: 68/100 (weight 15%)
Edwards Lifesciences Corp opportunities and risks
What speaks for EW
- Accelerating adoption of TMTT portfolio (PASCAL and EVOQUE)
What speaks against EW
- Product recall and safety warnings on SAPIEN M3 delivery systems
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| EW | 51.3x | 7.9x | 31.1x | 78.0% | 15.4% | 2.8% |
| ABT | 38.0x | 3.7x | 21.1x | 57.1% | 9.7% | 4.9% |
| ISRG | 52.7x | 13.5x | 35.6x | 67.2% | 25.5% | 2.3% |
| SYK | 31.5x | 4.5x | 19.3x | 65.2% | 14.4% | 4.0% |
| BSX | 18.5x | 3.2x | 13.5x | 71.2% | 17.5% | 5.5% |
| BDX | 59.7x | 2.6x | 15.7x | 46.1% | 4.5% | 4.8% |
| Peer median | 38.0x | 3.7x | 19.3x | 65.2% | 14.4% | 4.8% |
Frequently asked questions about Edwards Lifesciences Corp (EW)
Is EW stock a good investment?
The TradeMates model rates Edwards Lifesciences Corp as HOLD with an investment score of 63/100. The TradeMates model views EW as a high-quality MedTech leader trading at premium valuation multiples that reflect strong growth prospects in tricuspid/mitral structural heart therapies. This is algorithmic model output, not personal investment advice.
Is EW stock a buy?
The TradeMates model verdict for EW is HOLD with an investment score of 63/100. Treat this as a model signal to review, not a personal buy recommendation.